ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Astrazeneca Sweden Investments Limited

Astrazeneca Sweden Investments Limited is an active company incorporated on 8 April 2003 with the registered office located in Cambridge, Cambridgeshire. Astrazeneca Sweden Investments Limited was registered 22 years ago.
Status
Active
Active since incorporation
Company No
04726837
Private limited company
Age
22 years
Incorporated 8 April 2003
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 8 April 2025 (6 months ago)
Next confirmation dated 8 April 2026
Due by 22 April 2026 (6 months remaining)
Last change occurred 6 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge
CB2 0AA
United Kingdom
Same address for the past 9 years
Telephone
02076048000
Email
Unreported
People
Officers
5
Shareholders
1
Controllers (PSC)
1
Director • Head Of Tax Sweden • Swedish • Lives in Sweden • Born in Oct 1964
Director • Group Treasurer • British • Lives in UK • Born in Nov 1965
Director • None • British • Lives in UK • Born in Dec 1970
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Astrazeneca Treasury Limited
Iain Alistair Collins and Jonathan Thomas Charles Slade are mutual people.
Active
Astrazeneca Intermediate Holdings Limited
Iain Alistair Collins and Jonathan Thomas Charles Slade are mutual people.
Active
Astra Pharmaceuticals Limited
Iain Alistair Collins is a mutual person.
Active
Astrapharm
Iain Alistair Collins is a mutual person.
Active
Medimmune Limited
Iain Alistair Collins is a mutual person.
Active
Astrazeneca Finance Limited
Iain Alistair Collins is a mutual person.
Active
Cambridge Antibody Technology Group Limited
Iain Alistair Collins is a mutual person.
Active
Kudos Pharmaceuticals Limited
Iain Alistair Collins is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
£940M
Increased by £940M (%)
Employees
Unreported
Same as previous period
Total Assets
£19.01B
Increased by £1.18B (+7%)
Total Liabilities
-£514M
Increased by £12M (+2%)
Net Assets
£18.49B
Increased by £1.17B (+7%)
Debt Ratio (%)
3%
Decreased by 0.11% (-4%)
Latest Activity
Full Accounts Submitted
4 Months Ago on 2 Jun 2025
Camilla Johnstone Appointed
5 Months Ago on 1 May 2025
Matthew Shaun Bowden Resigned
5 Months Ago on 1 May 2025
Confirmation Submitted
6 Months Ago on 11 Apr 2025
Full Accounts Submitted
1 Year 5 Months Ago on 23 May 2024
Confirmation Submitted
1 Year 6 Months Ago on 11 Apr 2024
Full Accounts Submitted
2 Years 3 Months Ago on 4 Jul 2023
Confirmation Submitted
2 Years 6 Months Ago on 23 Apr 2023
Full Accounts Submitted
3 Years Ago on 15 Jul 2022
Confirmation Submitted
3 Years Ago on 22 Apr 2022
Get Credit Report
Discover Astrazeneca Sweden Investments Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 December 2024
Submitted on 2 Jun 2025
Appointment of Camilla Johnstone as a secretary on 1 May 2025
Submitted on 1 May 2025
Termination of appointment of Matthew Shaun Bowden as a secretary on 1 May 2025
Submitted on 1 May 2025
Confirmation statement made on 8 April 2025 with updates
Submitted on 11 Apr 2025
Memorandum and Articles of Association
Submitted on 27 Nov 2024
Resolutions
Submitted on 27 Nov 2024
Full accounts made up to 31 December 2023
Submitted on 23 May 2024
Confirmation statement made on 8 April 2024 with no updates
Submitted on 11 Apr 2024
Full accounts made up to 31 December 2022
Submitted on 4 Jul 2023
Confirmation statement made on 8 April 2023 with updates
Submitted on 23 Apr 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year